BioWorld: A three-armed activator of natural killer cells against head and neck squamous cell carcinoma
Prognosis is extremely poor for patients with head and neck squamous cell carcinoma (HNSCC), which accounts for around 90% of all head and neck cancer. Especially in the more aggressive subtype of ...
A three-armed activator of natural killer cells against head and neck squamous cell carcinoma
A benign esophageal cell papilloma is a small, noncancerous tumor that forms in the esophagus. Most do not cause symptoms. Doctors treat the growth by removing it. A papilloma is a benign ...
News Medical: Mutation profiles and clinicopathological correlations in lung squamous cell carcinoma
Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...
EurekAlert!: Relationship between mutation profile detected by next-generation sequencing and histopathological parameters in lung squamous cell carcinoma
Relationship between mutation profile detected by next-generation sequencing and histopathological parameters in lung squamous cell carcinoma
Squamous cell carcinoma is a type of skin cancer. Treatment options include different types of surgery, radiation therapy, topical medications, light therapy, and more. Squamous cell carcinoma usually ...
Abemaciclib in recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC) harboring CDKN2A loss, and/or CCND1 and/or CDK6 amplification: A phase II multicenter trial. This is an ASCO ...
Squamous cell lung cancer starts in the squamous cells: thin, flat cells that line the inside of the airways in your lungs. If you're diagnosed after the cancer has spread, it tends to be more ...
ascopubs.org: Prognostic value of three microRNA expression profiles in early-stage squamous cell lung cancer (SqCLC).